Abstract. Background. The Bethesda Classification for Reporting Thyroid Cytopathology (BSRTC) was developed in 2010 to provide a standardized framework for interpreting and reporting FNA cytology, and its use is recommended for the evaluation of thyroid nodules in both adults and children.
Material and methods. A retrospective analysis of 51 patients with thyroid nodules was performed. Of the 51 patients, 33 were men and 18 were women.
Research methods - general clinical, biochemical (bilirubin, direct, indirect, ALT, AST, PTI, coagulogram, CRP), hormonal (TSH, free thyroxine, antibodies to thyroid peroxidase, to thyroglobulin and thyrocyte receptors, prolactin in the blood) and instrumental: ECG, Ultrasound of the thyroid gland, internal organs, chest x-ray, as well as fine-needle aspiration biopsy (FNA).
Research results. The patients were divided into 2 groups: group 1 - patients with one nodular thyroid formation - 35 patients, group 2 - patients with multinodular thyroid formations - 16 patients. 20 healthy individuals made up the control group.
Conclusions.1) The majority of patients, a total of 22 out of 51 patients, belonged to Bethesda category II (43.1%), while 2 - category I (3.9%), 6 - category III (11.8%), 12 - category IV (23.5%), 7 - category V (13.7%) and 2 patients belonged to category VI (3.9%) respectively. 2 patients with Bethesda category I underwent repeat FNA, and later they had category II. 2) When analyzing the cytological response, the Bethesda classification must be used for correct prognosis and treatment.
References:
1. Pitman MB, Abele J, Ali SZ, Duick D, Elsheikh TM, Jeffrey RB, et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. //Diagnost Cytopathol. 2008;36:407–424.
2. Silverman JF, West RL, Finley JL, Larkin EW, Park HK, Swanson MS, et al. Fine-needle aspiration versus large-needle biopsy or cutting biopsy in evaluation of thyroid nodules. //Diagnost Cytopathol. 1986;2:25–30.
3. Wang C, Vickery AL, Jr, Maloof F. Needle biopsy of the thyroid. //Surg Gynecol Obstet. 1976;143:365–368.
4. Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. //Anticancer Res. 2000;20:3843–3847.
5. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules--2016 Update. //Endocr Pract. 2016;22:622–639.
6. Tee YY, Lowe AJ, Brand CA, Judson RT. Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg. 2007;246:714–720.
7. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. //Thyroid. 2011;21:243–251. [
8. Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002;87:4924–4927.
9. Orija IB, Piñeyro M, Biscotti C, Reddy SS, Hamrahian AH. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy. // Endocr Pract. 2007;13:735–742.
10. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer. 2009;117:195–202.
11. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. //Cancer. 2007;111:306–315.
12. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. //Cancer. 2007;111:508–516.
13. Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. Cytojournal. 2006;3:9.
14. Yoo C, Choi HJ, Im S, Jung JH, Min K, Kang CS, et al. Fine needle aspiration cytology of thyroid follicular neoplasm: cytohistologic correlation and accuracy. //Korean J Pathol. 2013;47:61–66.
15. Yeon JS, Baek JH, Lim HK, Ha EJ, Kim JK, Song DE, et al. Thyroid nodes with initially nondiagnostic cytologic results: the role of core-needle biopsy. //Radiology. 2013;268:274–280.
16. Novoa E, Gürtler N, Arnoux A, Kraft M. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. //Head Neck. 2012;34:1497–1503.
17. Liu Q, Castelli M, Gattuso P, Prinz RA. Simultaneous fine-needle aspiration and core-needle biopsy of thyroid nodules. //Am Surg. 1995;61:628–632. discussion 632-633
18. Pires AT, Mustafá AMM, Magalhães MOG. The 2017 ACR TI-RADS: pictorial essay. //Radiol Bras. 2022 Jan-Feb;55(1):47-53. doi: 10.1590/0100-3984.2020.0141.
19. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Hammers LW, Hamper UM, Langer JE, Reading CC, Scoutt LM, Stavros AT. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. //J Am Coll Radiol. 2017 May;14(5):587-595. doi: 10.1016/j.jacr.2017.01.046.
20. Cibas ES1, Ali SZ. The Bethesda System For Reporting Thyroid Cytopathology.// Am J Clin Pathol. 2009 Nov;132(5):658-65. doi: 10.1309/AJCPPHLWMI3JV4LA.; NCI Thyroid FNA State of the Science Conference.
SCIENCE & INNOVATION